This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Bennett Smith
SVP, GM North America at Orchard Therapeutics
Speaker

Profile

Bennett Smith is an innovative leader in the pharmaceutical and biotech industries, known for his transformative impact on commercial strategy and market access. With over 20 years of experience, Bennett has consistently demonstrated his ability to launch blockbuster brands and rejuvenate mature products, driving significant growth and revenue for industry giants such as Akebia Therapeutics, Regeneron, and Novo Nordisk.

Currently serving as Senior Vice President and General Manager for North America at Orchard Therapeutics, Bennett is at the forefront of pioneering therapies, leading the U.S. commercial launch of a first-in-class cell and gene therapy for an ultra-rare pediatric condition.

Agenda Sessions

  • Conquering the Unchartered – Bringing Rare Disease Therapy to Patients

    2:05pm